View the HOFTREX registration information details.
Back to drug list
ItemsDrug Registration information
ID313
No313
Brand NameHOFTREX
IngredientsCEFTRIAXONE SODIUM EQ. TO CEFTRIAXONE 1 G
Dosage FormPOWDER FOR SOLUTION FOR INJECTION
Primary PackagingVIAL
Storage
Shelf Life3 YEARS
Pack SizeBOX OF 1 VIAL + 1 AMP. 10 ML WFI
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsBONE AND JOINT INFECTION, UNCOMPLICATED GONORHHOEA, INTRA-ABDOMINAL INFECTIONS, LYME DISEASE, MENINGITIS, OTITIS MEDIA, FEMALE PELVIC INFECTIONS, RESPIARATORY TRACT INFECTION PARTICULARLY BACTERIAL PNEUMONIA, BACTERIAL SEPTICAEMIA, SKIN AND SOFT TISSUE INFECTIONS, BACTERIAL URINARY TRACT INFECTIONS
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionWHITE TO YELLOWISH ORANGE CRYSTALLINE POWDER
Note
License OwnerBMS PHARMA SOLE CO.,LTD
ManufacturerNECTAR LIFESCIENCES LIMITED (UNIT-VI)
CountryMALAYSIA
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No05 I 4703/19
FDD Registration Date07/07/2025
Expiry Date06/07/2030
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA